Impact Factor
2.81
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.84
107 total citations
h5-index
14
h5 depth signal
Cited share
72.4%
42 of 58
Total citations
107
Citation footprint
Metric signal
1.70
External metric anchor
Self-citation
9.3%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
228
Canada
27
Australia
26
Spain
20
United Kingdom
15
Citing Fields of Research
Substance Abuse
248
Psychiatry
158
Psychiatry & Psychology
82
Nicotine Addiction Treatment
46
Neurosciences
19
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
806
Articles tracked across the journal lifetime
Indexed publication set
58
42 cited publications
Last 12 months
44
4.9 publications/month
Open access share
6.8%
3 OA publications in the last year
Leading citing country
United States
228 citing publications
Leading citing field
Substance Abuse
248 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v10n1, Jan./Mar. 2014-
v10n1, Jan./Mar. 2014-
Research Focus & Classification
Indexed Subjects
Substance Abuse
Psychiatry
Psychiatry & Psychology
Broad Categories
Psychiatry
Substance-Related Disorders
Substance Abuse
Psychiatry & Psychology
MeSH Descriptors
Diagnosis, Dual (Psychiatry)
Mental Disorders
Substance-Related Disorders.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/15504263.2026.2726792
Open DOI
Treatment Outcomes for Co-Occurring Borderline Personality Disorder and Substance Use Disorders: A Systematic Review
02
DOI 10.1080/15504263.2026.2726799
Open DOI
Patterns and Correlates of Suicidality Among People With Opioid Dependence—A Cross-Sectional, Community-Based Study
Suicide remains a major global public health concern and is among the leading causes of death in young and working-age populations worldwide (Ferrari et al., 2014; Suicide Worldwide in 2019, 2021)....
03
DOI 10.1080/15504263.2026.2729324
Open DOI
Specific Mental Disorder Comorbidities and MOUD Receipt for Opioid Misuse: Lower Receipt for Persons with Psychotic Disorders
04
05
DOI 10.1080/15504263.2026.2726788
Open DOI
Reduced Agitation in Psychiatric Inpatients Associated with Increased Exposure to Nicotine Replacement
Tobacco use is overrepresented in psychiatric inpatients. People with any mental health issue are 2–3 times more likely to smoke tobacco with prevalence amongst those with psychotic disorders up to...
06
DOI 10.1080/15504263.2026.2726798
Open DOI
Understanding Nicotine Use in Schizophrenia Through a Psychosocial Lens: A Narrative Review
Individuals with schizophrenia exhibit heightened vulnerability to comorbid substance use particularly nicotine dependence, which is five times more prevalent than in the general population (Green ...
07
08
DOI 10.1080/15504263.2026.2726791
Open DOI
Psychiatric Severity and Resilience in Outpatients Seeking Treatment for Cocaine Use Disorder
According to the World Health Organization (WHO; World Drug Report 2024, 2024), an estimated 22 million individuals used cocaine over the past year worldwide, of whom approximately 16% (Farrell et ...
09
10
Bibliographical & Catalog Notes
Also issued online.